← FDA Drug Approvals (Drugs@FDA)

BAVENCIO

BLA · Biologics License Application · Sponsor: EMD SERONO INC · Approved 2017-03-23

Drug application

FDA Application #
BLA761049
Application type
Biologics License Application
Brand name
BAVENCIO
Generic name
AVELUMAB
Active ingredients
AVELUMAB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
EMD SERONO INC
Manufacturer
EMD Serono, Inc.
First approval
2017-03-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown